Management of Intestinal Amoebiasis
Diagnosis and Clinical Presentation
- Intestinal amoebiasis is caused by Entamoeba histolytica and should be confirmed by identifying the parasite in stool samples through microscopy or PCR before initiating treatment 1
- Clinical presentation may range from asymptomatic cyst passage to symptomatic disease with diarrhea and abdominal pain 1
- Diagnosis should include concentrated stool microscopy or fecal PCR to identify E. histolytica 3
Treatment Regimen
- Metronidazole 750 mg orally three times daily for 5-10 days is the recommended first-line treatment for intestinal amoebiasis 1, 2
- After treatment with metronidazole, all patients must receive a luminal amebicide to eliminate intestinal cysts and prevent relapses 2
- Options for luminal agents include paromomycin 500 mg three times daily for 7 days 1, 2 and diloxanide furoate 500 mg three times daily for 10 days 2
Special Populations
- For immunocompromised patients, the same treatment regimen is recommended as for immunocompetent patients 1
Treatment Efficacy and Considerations
- A two-phase approach using both tissue and luminal agents is essential to prevent relapse 2
Monitoring and Follow-up
- Clinical improvement should occur within 48 hours of initiating therapy 1
- If symptoms persist despite appropriate therapy, consider resistance or misdiagnosis 1